EPS15, CPTAC-966 - CPTAC Assay Portal
- ️ABCC's Scientific Web Programming Group, Frederick National Laboratory for Cancer Research (FNLCR)
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.
Protein Sequence hover to view complete sequence
10 | 20 | 30 | 40 | 50 |
MAAAAQLSLT | QLSSGNPVYE | KYYRQVDTGN | TGRVLASDAA | AFLKKSGLPD |
60 | 70 | 80 | 90 | 100 |
LILGKIWDLA | DTDGKGILNK | QEFFVALRLV | ACAQNGLEVS | LSSLNLAVPP |
110 | 120 | 130 | 140 | 150 |
PRFHDTSSPL | LISGTSAAEL | PWAVKPEDKA | KYDAIFDSLS | PVNGFLSGDK |
160 | 170 | 180 | 190 | 200 |
VKPVLLNSKL | PVDILGRVWE | LSDIDHDGML | DRDEFAVAMF | LVYCALEKEP |
210 | 220 | 230 | 240 | 250 |
VPMSLPPALV | PPSKRKTWVV | SPAEKAKYDE | IFLKTDKDMD | GFVSGLEVRE |
260 | 270 | 280 | 290 | 300 |
IFLKTGLPST | LLAHIWSLCD | TKDCGKLSKD | QFALAFHLIS | QKLIKGIDPP |
310 | 320 | 330 | 340 | 350 |
HVLTPEMIPP | SDRASLQKNI | IGSSPVADFS | AIKELDTLNN | EIVDLQREKN |
360 | 370 | 380 | 390 | 400 |
NVEQDLKEKE | DTIKQRTSEV | QDLQDEVQRE | NTNLQKLQAQ | KQQVQELLDE |
410 | 420 | 430 | 440 | 450 |
LDEQKAQLEE | QLKEVRKKCA | EEAQLISSLK | AELTSQESQI | STYEEELAKA |
460 | 470 | 480 | 490 | 500 |
REELSRLQQE | TAELEESVES | GKAQLEPLQQ | HLQDSQQEIS | SMQMKLMEMK |
510 | 520 | 530 | 540 | 550 |
DLENHNSQLN | WCSSPHSILV | NGATDYCSLS | TSSSETANLN | EHVEGQSNLE |
560 | 570 | 580 | 590 | 600 |
SEPIHQESPA | RSSPELLPSG | VTDENEVTTA | VTEKVCSELD | NNRHSKEEDP |
610 | 620 | 630 | 640 | 650 |
FNVDSSSLTG | PVADTNLDFF | QSDPFVGSDP | FKDDPFGKID | PFGGDPFKGS |
660 | 670 | 680 | 690 | 700 |
DPFASDCFFR | QSTDPFATSS | TDPFSAANNS | SITSVETLKH | NDPFAPGGTV |
710 | 720 | 730 | 740 | 750 |
VAASDSATDP | FASVFGNESF | GGGFADFSTL | SKVNNEDPFR | SATSSSVSNV |
760 | 770 | 780 | 790 | 800 |
VITKNVFEET | SVKSEDEPPA | LPPKIGTPTR | PCPLPPGKRS | INKLDSPDPF |
810 | 820 | 830 | 840 | 850 |
KLNDPFQPFP | GNDSPKEKDP | EIFCDPFTSA | TTTTNKEADP | SNFANFSAYP |
860 | 870 | 880 | 890 | 896 |
SEEDMIEWAK | RESEREEEQR | LARLNQQEQE | DLELAIALSK | SEISEA |
Data source: UniProt
Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs
Uniprot Database Entry PhosphoSitePlus ®
Click a point on a node
to view detailed assay information below
All other points link out to UniProt
loading
Assay Details for CPTAC-966 Collapse assay details
Data source: Panorama
-
Official Gene Symbol
- EPS15 Peptide Modified Sequence
- IGT[+80.0]PTRPC[+57.0]PLPPGK Modification Type
- Phospho (ST), Carbamidomethyl Cysteine Protein - Site of Modification
- 777, 782 Peptide - Site of Modification
- 3, 8 Peptide Start
- 775 Peptide End
- 788
-
CPTAC ID
- CPTAC-966 Peptide Molecular Mass
- 1,569.7739 Species
- Homo sapiens (Human) Assay Type
- Enrichment MRM Enrichment Method
- IMAC Matrix
- cell lysate Submitting Laboratory
- Fred Hutchinson Cancer Research Center Submitting Lab PI
- Amanda Paulovich
Publication
View Details (opens in a new window)
Kennedy JJ, Yan P, Zhao L, Ivey RG, Voytovich U, Moore HD, Lin C, Pogosova-Agadjanyan EL, Stirewalt DL, Reding KW, Whiteaker JR, Paulovich AG. Immobilized metal affinity chromatography coupled to multiple reaction monitoring enables reproducible quantification of phospho-signaling. Molecular and Cellular Proteomics. mcp.O115.054940
Assay Parameters Collapse assay parameters
Data source: Panorama
-
Instrument
- QTrap 5500 (Sciex) Internal Standard
- synthetic peptide Peptide Standard Purity
- Crude Peptide Standard Label Type
- 13C and 15N at C-terminus K
-
LC
- nanoLC-2D (Eksigent) Column Packing
- ChromXP C18-CL, 3 µm, 120 Å Column Dimensions
- 75 µm x 15cm Flow Rate
- 300 nL/min
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV![]() |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y11 (2+) | 21.5 | 8.8 | 11.9 | 22.1 | 9.1 | 13.7 | 30.8 | 12.7 | 18.1 | 15 | 24 | 15 |
y13-98 (2+) | 50.9 | 17.7 | 17.9 | 60.5 | 18.3 | 19.3 | 79.1 | 25.5 | 26.3 | 15 | 24 | 15 |
y13 (2+) | 29.8 | 14.8 | 16.9 | 25.9 | 13.1 | 16.3 | 39.5 | 19.8 | 23.5 | 15 | 24 | 15 |
sum | 25.8 | 8.7 | 12.3 | 23.6 | 8 | 12.1 | 35 | 11.8 | 17.3 | 15 | 24 | 15 |
Additional Resources and Comments
Assay Details for CPTAC-967 Collapse assay details
Data source: Panorama
-
Official Gene Symbol
- EPS15 Peptide Modified Sequence
- LDS[+80.0]PDPFK Modification Type
- Phospho (ST) Protein - Site of Modification
- 796 Peptide - Site of Modification
- 3 Peptide Start
- 794 Peptide End
- 801
-
CPTAC ID
- CPTAC-967 Peptide Molecular Mass
- 997.4158 Species
- Homo sapiens (Human) Assay Type
- Enrichment MRM Enrichment Method
- IMAC Matrix
- cell lysate Submitting Laboratory
- Fred Hutchinson Cancer Research Center Submitting Lab PI
- Amanda Paulovich
Publication
View Details (opens in a new window)
Kennedy JJ, Yan P, Zhao L, Ivey RG, Voytovich U, Moore HD, Lin C, Pogosova-Agadjanyan EL, Stirewalt DL, Reding KW, Whiteaker JR, Paulovich AG. Immobilized metal affinity chromatography coupled to multiple reaction monitoring enables reproducible quantification of phospho-signaling. Molecular and Cellular Proteomics. mcp.O115.054940
Assay Parameters Collapse assay parameters
Data source: Panorama
-
Instrument
- QTrap 5500 (Sciex) Internal Standard
- synthetic peptide Peptide Standard Purity
- Crude Peptide Standard Label Type
- 13C and 15N at C-terminus K
-
LC
- nanoLC-2D (Eksigent) Column Packing
- ChromXP C18-CL, 3 µm, 120 Å Column Dimensions
- 75 µm x 15cm Flow Rate
- 300 nL/min
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV![]() |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
b5 (1+) | 11.1 | 11.9 | 12.8 | 34.6 | 16.2 | 16.4 | 36.3 | 20.1 | 20.8 | 15 | 24 | 15 |
y5 (1+) | 13.2 | 10.9 | 9.8 | 27.5 | 14.7 | 14.8 | 30.5 | 18.3 | 17.8 | 15 | 24 | 15 |
y7 (1+) | 11.8 | 11.9 | 12.2 | 27.7 | 14.8 | 14.6 | 30.1 | 19 | 19 | 15 | 24 | 15 |
sum | 11.3 | 9.7 | 9.2 | 28.2 | 14.2 | 13.2 | 30.4 | 17.2 | 16.1 | 15 | 24 | 15 |